产品中心 流式试剂&相关 流式抗体

所有图片(1/1)

APC-Cy7 Mouse Anti-Human CD19 Antibody (S-1039-46)

B-lymphocyte antigen CD19,B-lymphocyte surface antigen B4,Differentiation antigen CD19,T-cell surface antigen Leu-12

价格 询价 请咨询客服
货号 S0B8745
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD19
  • 分子别名

    B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Cell membrane
  • Accession

    P15391
  • 克隆号

    S-1039-46
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG1,k
  • 反应种属 ?

    RhMk, CyMk, Hu
  • 阳性样本

    Human PBMC
  • 纯化方式

    Protein G
  • 浓度

    0.2 mg/ml
  • 标记

    APC-Cy7
  • 性状

    Liquid
  • 缓冲体系

    PBS, 1% BSA, 0.3% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

  • 应用

    FCM

  • 稀释度

    应用 稀释度 推荐种属
    FCM 1.25μl per million cells in 100μl volume Hu
背景介绍
  • CD19, also known as B-lymphocyte antigen CD19 or B-Lymphocyte Surface Antigen B4, is a 95 kDa type I transmembrane glycoprotein that belongs to the immunoglobulin superfamily and is encoded by the CD19 gene. It is primarily expressed on all B lineage cells, from early pro-B cells to plasma cells, and plays a crucial role in B cell development, activation, and signaling. As a co-receptor, CD19 enhances signaling through the B cell receptor (BCR) complex, lowering the threshold for B cell activation and promoting B cell proliferation and differentiation. It forms a complex with CD21, CD81, and other proteins, which helps in the recognition of antigens tagged with complement and amplifies BCR signaling. CD19 is also a biomarker for B cell-related diseases and a target for immunotherapies, including monoclonal antibodies and CAR-T cell therapies, due to its consistent expression on B cells and B cell malignancies.

  • 流式分析

    • Flow cytometric analysis of Human CD19 expression on human PBMC (human peripheral blood mononuclear cell). Human PBMC were stained with Brilliant Violet 421™ Mouse Anti-Human CD3 antibody and either APC-Cy7 Mouse IgG1, κ Isotype Control (left panel) or SDT APC-Cy7 Mouse Anti-Human CD19 Antibody (right panel) at 1.25 μl/test treated with True-Stain Monocyte Blocker™. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.

评论(0)